Topical application of a novel anti-interleukin-17A antibody fragment penetrates psoriatic skin: Results of a randomized, double-blind, placebo-controlled phase 1b study - supplementary data

Name: Topical application of a novel anti-interleukin-17A antibody fragment penetrates psoriatic skin: Results of a randomized, double-blind, placebo-controlled phase 1b study - supplementary data
Creator: Rod Sinclair
Published: 2022-09-12T19:34:14.432Z
Keywords: Cytokines, General Dermatology, Medical Dermatology, Immunodermatology, Psoriasis

Sinclair, Rod; Sharifeh, Sammy; Thackwray, Susan; Lickliter, Jason; Wu, Junlong; Li, Jing; Qi, Bei; Bland-Ward, Philip; Reinhart, Harald

doi:10.17632/j6ys2x8g4g.1

Topical application of a novel anti-interleukin-17A antibody fragment penetrates psoriatic skin: Results of a randomized, double-blind, placebo-controlled phase 1b study - supplementary data

Published: 12 September 2022| Version 1 | DOI: 10.17632/j6ys2x8g4g.1

Contributors:

Rod Sinclair, Sammy Sharifeh, Susan Thackwray, Jason Lickliter, Junlong Wu, Jing Li, Bei Qi, Philip Bland-Ward, Harald Reinhart

Description

Supplementary methods, tables and figures

Topical application of a novel anti-interleukin-17A antibody fragment penetrates psoriatic skin: Results of a randomized, double-blind, placebo-controlled phase 1b study - supplementary data

Description

Files

Categories

Licence